(ANSA) - BERLIN, 24 JAN - Germany will become the first country in the European Union to use the experimental antibody-based treatment administered to Donald Trump against Covid-19. Health Minister Jens Spahn announced this Sunday.
"The government bought 200,000 doses for 400 million euros," he told the Bild am Sonntag newspaper. This "monoclonal" antibody cocktaild will be used in university hospitals next week, the minister said.
(HANDLE).